Publicis


Return to organic growth expected after Q1 21

22/02/21 -"The change in the target price is derived from the update of our 2021-22 estimates with a minor impact on the valuation. An organic negative trend at the top line is expected in Q1 21 (our estimate ..."

Pages
58
Language
English
Published on
22/02/21
You may also be interested by these reports :
07/10/26
Last time we teased RELX (ADD; UK) in early January 2025, the stock was near its ATH, being recognised as a GenAI winner. The story changed abruptly ...

06/10/26
Informa has announced its intention to become a B2B Events pure player, triggering a process to divest its publishing arm, Taylor & Francis, and the ...

30/09/26
CTS Eventim abruptly announced the departure of its CFO with immediate effect, which suggests a significant disagreement with the CEO-founder in our ...

08/09/26
About a year ago we flagged Pearson’s quiet reinvention from “the company that used to sell you textbooks” into an assessment powerhouse — a neat ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO